PTC Therapeutics Inc (NAS:PTCT)
$ 36.53 3.23 (9.7%) Market Cap: 2.80 Bil Enterprise Value: 2.34 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

PTC Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2020 / 02:30PM GMT
Release Date Price: $60 (+1.27%)
Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Okay. Hey, everybody. I am Marty Auster. I'm the lead SMID cap biotech analyst at Crédit Suisse. Welcome to the 29th Annual Crédit Suisse Healthcare Conference, First Virtual Conference. I'm happy to have PTC Therapeutics today.

I've got Stu Peltz, CEO of the company, along with several members of the team. Stu, I was just about to say in the breakout. I was -- I had every best intention to kind of do this in front of a fireplace, and it's been like 70-plus degrees all week in Vermont and apparently warmer than in Phoenix. So I don't know what to say, but maybe next year, we'll actually get a fire.

But let me hand it over to you to introduce who's all joining you today from the team. And maybe if you could also just make an intro kind of an overview comment about kind of the PTC vision.

Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director

Sure. Thanks for having us. Sort of nice to be in warm Vermont, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot